We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > APEIRON

News List

Latest Updates of Viva Biotech's Portfolio Companies PRNewswire
January 08, 2025
Recently, Viva Biotech's portfolio companies have new updates: TechnoDerma, VivaVision, Arthrosi, Apeiron Therapeutics and AceLink made solid progress in R&D; Full Circles published breakthrough results; Antag successfully completed financing.
APEIRON Biologics’ APN01 Selected for US COVID-19 Trail americanpharmaceuticalreview
May 20, 2021
APEIRON Biologics, a private European biotech company, announced next steps for APN01 (alunacedase alfa) for COVID-19 treatment.
APEIRON Appoints CMSO contractpharma
August 29, 2018
APEIRON Biologics AG has appointed Anderson Gaweco, M.D., Ph.D. as its chief medical and scientific officer (CMSO).